Comparison of supervision on illegal behaviors of fake and inferior drugs between China and India
XIAO Yan
Abstract：Objective To compare the current situation of the supervision of counterfeit and inferior drugs in China and India,study their internal causes,and provide reference and ideas for strengthening the drug supervision in China.Methods By using the literature research method and comparative research method,this paper compares the current situa-tion of the supervision of counterfeit and shoddy drugs in China and India,analyzes the causes of the illegal behaviors of counterfeit and shoddy drugs in the two countries,analyzes the existing shortcomings,the differences between the regulatory laws and regulations and legal concepts of the two countries,and puts forward targeted policy suggestions on the drug regula-tory system suitable for China's national conditions.Results China and India are both developing countries and major phar-maceutical countries,but each has its own experience and shortcomings in regulating the illegal behavior of counterfeit and substandard drugs.Conclusion Generally speaking,although China has made progress in punishing drug violations,it still needs to carry out more profound system reform in combination with the national conditions.The concept of inferior drugs should be abolished and the legal net should be tightened;Strengthen supervision and technical support;Strengthen the pub-licity of laws and regulations and improve the implementation of policies;We will guide the technological upgrading of the pharmaceutical industry and further strengthen the effectiveness of drug regulation.
Keywords：ChinaIndiaFake and inferior drugsDrug violationsDrug management law
Publication Date：2023-12-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：6( 1051-1056 )